Terms: = Bone cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Treatment
291 results:
1. Polyphyllin I enhances tumor necrosis factor-related apoptosis-inducing ligand-induced inhibition of human osteosarcoma cell growth downregulating the Wnt/β-catenin pathway.
Junli C; Fulai Z; Xingyuan S; Xiaoping MA; Peng Z; Chujie Z; Binhao S; Wenchao GU; Yongjun W; Yanping Y
J Tradit Chin Med; 2024 Apr; 44(2):251-259. PubMed ID: 38504531
[TBL] [Abstract] [Full Text] [Related]
2. Identification of COQ2 as a regulator of proliferation and lipid peroxidation through genome-scale CRISPR-Cas9 screening in myeloma cells.
Li M; Zhang CL; Zhou DS; Chan SH; Liu XQ; Chen SN; Yang ZY; Ju FE; Sang XY; Liu ZX; Zhang QX; Pan YM; Deng SS; Wang XM; Zhong L; Zhang XD; Du X
Br J Haematol; 2024 Apr; 204(4):1307-1324. PubMed ID: 38462771
[TBL] [Abstract] [Full Text] [Related]
3. Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library.
Yada Y; Asanuma K; Kakimto T; Okuno K; Okamoto T; Iino T; Nakamura T; Sudo A
Anticancer Res; 2024 Mar; 44(3):1071-1078. PubMed ID: 38423639
[TBL] [Abstract] [Full Text] [Related]
4. Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index.
Wang Y; Ma X; Xu E; Huang Z; Yang C; Zhu K; Dong Y; Zhang C
Clin Transl Med; 2024 Feb; 14(2):e1586. PubMed ID: 38372422
[TBL] [Abstract] [Full Text] [Related]
5. Up-regulation of RAN by MYBL2 maintains osteosarcoma cancer stem-like cells population during heterogeneous tumor generation.
Gao W; Zhou J; Huang J; Zhang Z; Chen W; Zhang R; Kang T; Liao D; Zhong L
Cancer Lett; 2024 Apr; 586():216708. PubMed ID: 38336287
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM).
Mill CP; Fiskus WC; DiNardo CD; Reville P; Davis JA; Birdwell CE; Das K; Hou H; Takahashi K; Flores L; Ruan X; Su X; Loghavi S; Khoury JD; Bhalla KN
Blood Cancer J; 2024 Feb; 14(1):25. PubMed ID: 38316746
[TBL] [Abstract] [Full Text] [Related]
7. Unraveling T cell exhaustion in the immune microenvironment of osteosarcoma via single-cell RNA transcriptome.
Cheng D; Zhang Z; Liu D; Mi Z; Tao W; Fu J; Fan H
Cancer Immunol Immunother; 2024 Jan; 73(2):35. PubMed ID: 38280005
[TBL] [Abstract] [Full Text] [Related]
8. An In Vitro Model for Acute Myeloid Leukemia Relapse Using the SORE6 Reporter.
Lai J; Shang C; Chen W; Izevbaye I; Chu MP; Sandhu I; Brandwein J; Lai R; Wang P
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203669
[TBL] [Abstract] [Full Text] [Related]
9. m
Zhang D; Guo Q; You K; Zhang Y; Zheng Y; Wei T
J Orthop Surg Res; 2024 Jan; 19(1):33. PubMed ID: 38178201
[TBL] [Abstract] [Full Text] [Related]
10. Collaborative effect of Csnk1a1 haploinsufficiency and mutant p53 in myc induction can promote leukemic transformation.
Fuchs SNR; Stalmann USA; Snoeren IAM; Bindels E; Schmitz S; Banjanin B; Hoogenboezem RM; van Herk S; Saad M; Walter W; Haferlach T; Seillier L; Saez-Rodriguez J; Dugourd AJF; Lehmann KV; Ben-Neriah Y; Gleitz HFE; Schneider RK
Blood Adv; 2024 Feb; 8(3):766-779. PubMed ID: 38147624
[TBL] [Abstract] [Full Text] [Related]
11. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation.
Kou R; Li T; Fu C; Jiang D; Wang Y; Meng J; Zhong R; Liang C; Dong M
Environ Res; 2024 Mar; 244():117783. PubMed ID: 38048862
[TBL] [Abstract] [Full Text] [Related]
12. Mitocurcumin utilizes oxidative stress to upregulate JNK/p38 signaling and overcomes Cytarabine resistance in acute myeloid leukemia.
Gaur T; Ali A; Sharma D; Gupta SK; Gota V; Bagal B; Platzbeckar U; Mishra R; Dutt A; Khattry N; Mills K; Hassan MI; Sandur S; Hasan SK
Cell Signal; 2024 Feb; 114():111004. PubMed ID: 38048856
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract] [Full Text] [Related]
14. A new histone deacetylase inhibitor remodels the tumor microenvironment by deletion of polymorphonuclear myeloid-derived suppressor cells and sensitizes prostate cancer to immunotherapy.
Chen Z; Yang X; Chen Z; Li M; Wang W; Yang R; Wang Z; Ma Y; Xu Y; Ao S; Liang L; Cai C; Wang C; Deng T; Gu D; Zhou H; Zeng G
BMC Med; 2023 Oct; 21(1):402. PubMed ID: 37880708
[TBL] [Abstract] [Full Text] [Related]
15. Posttreatment complications in pediatric cervical neuroblastoma: A retrospective case series at a tertiary cancer center.
Lopez J; Subramanian T; Durell J; Levyn H; Wong R; Shah J; LaQuaglia MP; Gerstle JT
J Surg Oncol; 2024 Feb; 129(2):219-223. PubMed ID: 37850570
[TBL] [Abstract] [Full Text] [Related]
16. The role of NFATc1 in the progression and metastasis of prostate cancer: A review on the molecular mechanisms and signaling pathways.
Hasani S; Fathabadi F; Saeidi S; Mohajernoei P; Hesari Z
Cell Biol Int; 2023 Dec; 47(12):1895-1904. PubMed ID: 37814550
[TBL] [Abstract] [Full Text] [Related]
17. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.
Kinnaman MD; Zaccaria S; Makohon-Moore A; Arnold B; Levine MF; Gundem G; Arango Ossa JE; Glodzik D; Rodríguez-Sánchez MI; Bouvier N; Li S; Stockfisch E; Dunigan M; Cobbs C; Bhanot UK; You D; Mullen K; Melchor JP; Ortiz MV; O'Donohue TJ; Slotkin EK; Wexler LH; Dela Cruz FS; Hameed MR; Glade Bender JL; Tap WD; Meyers PA; Papaemmanuil E; Kung AL; Iacobuzio-Donahue CA
Cancer Res; 2023 Nov; 83(22):3796-3812. PubMed ID: 37812025
[TBL] [Abstract] [Full Text] [Related]
18. Distinct and targetable role of calcium-sensing receptor in leukaemia.
Pereira RS; Kumar R; Cais A; Paulini L; Kahler A; Bravo J; Minciacchi VR; Krack T; Kowarz E; Zanetti C; Godavarthy PS; Hoeller F; Llavona P; Stark T; Tascher G; Nowak D; Meduri E; Huntly BJP; Münch C; Pampaloni F; Marschalek R; Krause DS
Nat Commun; 2023 Oct; 14(1):6242. PubMed ID: 37802982
[TBL] [Abstract] [Full Text] [Related]
19. Tumor-infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancer.
Jacover A; Zarbiv Y; Tal KH; Klein S; Breuer S; Durst R; Avni B; Grisariu S; Stepensky P; Lotem M; Maimon O; Yablonski-Peretz T
Cancer Rep (Hoboken); 2023 Dec; 6(12):e1894. PubMed ID: 37750497
[TBL] [Abstract] [Full Text] [Related]
20. The Targeted Therapies for Osteosarcoma
Wang S; Ren Q; Li G; Zhao X; Zhao X; Zhang Z
Curr Mol Pharmacol; 2024; 17(1):e210823220109. PubMed ID: 37602543
[TBL] [Abstract] [Full Text] [Related]
[Next]
